Marcus Yeo
Algemeen Directeur bij DefiniGEN Ltd.
Profiel
Marcus Yeo is the founder of DefiniGEN Ltd., AscendBio Ltd.
He previously worked as a Commercial Manager at CN Bio Innovations Ltd.
Actieve functies van Marcus Yeo
Bedrijven | Functie | Begin |
---|---|---|
DefiniGEN Ltd.
DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Algemeen Directeur | - |
Eerdere bekende functies van Marcus Yeo
Bedrijven | Functie | Einde |
---|---|---|
University of Oxford | Corporate Officer/Principal | - |
CN Bio Innovations Ltd.
CN Bio Innovations Ltd. BiotechnologyHealth Technology CN Bio Innovations Ltd. develops and supplies bioengineered solutions. Its products include liver chip system, tissue flex system, contract research services, drug safety profiling, drug metabolism, bespoke tissue models & applications development and technical support. The company was founded by Dr. Tim Hart on February 28, 2008 and is headquartered in Begbroke, the United Kingdom. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
CN Bio Innovations Ltd.
CN Bio Innovations Ltd. BiotechnologyHealth Technology CN Bio Innovations Ltd. develops and supplies bioengineered solutions. Its products include liver chip system, tissue flex system, contract research services, drug safety profiling, drug metabolism, bespoke tissue models & applications development and technical support. The company was founded by Dr. Tim Hart on February 28, 2008 and is headquartered in Begbroke, the United Kingdom. | Health Technology |
DefiniGEN Ltd.
DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Commercial Services |